Notification for amendment in Quality Control Order for Ortho Phosphoric Acid

## Report on the Ortho Phosphoric Acid Quality Control Order, 2021 **1. Executive Summary:** This report analyzes the "Ortho Phosphoric Acid Quality Control Order, 2021" based on the official gazette notification. This new policy mandates that all Ortho Phosphoric Acid (excluding exports) must conform to Indian Standard IS 798: 2020 and bear the Standard Mark under a license from the Bureau of Indian Standards (BIS). The primary purpose is to ensure the quality of Ortho Phosphoric Acid available in the domestic market. Key findings include the specification of BIS as the certifying and enforcing authority and penalties for non-compliance under the Bureau of Indian Standards Act, 2016. **2. Introduction:** This report provides an overview and analysis of the Ortho Phosphoric Acid Quality Control Order, 2021, as detailed in the provided government policy text. The purpose is to inform stakeholders about the policy's requirements, implementation, and potential impact. **3. Policy Overview:** * This is a *New Policy*. * **Core Objective(s):** Based on the provided text, the primary objective is to ensure the quality of Ortho Phosphoric Acid available for domestic use by mandating conformity to specific Indian Standards and certification through the Bureau of Indian Standards. **4. Background and Rationale:** Since this is a new policy, it can be inferred that the rationale behind it is to address potential quality issues with Ortho Phosphoric Acid in the domestic market. The policy likely aims to protect consumers and ensure fair trade practices by enforcing a minimum quality standard and providing a mechanism for certification and enforcement. The need to regulate the quality of Ortho Phosphoric Acid suggests there may have been inconsistencies or concerns in the past. **5. Key Provisions:** The Ortho Phosphoric Acid Quality Control Order, 2021, establishes the following key provisions: * **Scope:** The order applies to Ortho Phosphoric Acid intended for domestic use. It explicitly *does not* apply to products meant for export. * **Standard Conformity:** All Ortho Phosphoric Acid must conform to Indian Standard IS 798: 2020, titled "Ortho Phosphoric Acid Specification." * **Standard Mark Requirement:** Products must bear the Standard Mark under a license from the Bureau of Indian Standards (BIS) as per Scheme II of Schedule II of the Bureau of Indian Standards Conformity Assessment Regulations, 2018. * **Certification and Enforcement Authority:** The Bureau of Indian Standards (BIS) is designated as the sole certifying and enforcing authority for this order. * **Penalties:** Violations of this order will be punishable under the provisions of the Bureau of Indian Standards Act, 2016. * **Effective Date:** The order comes into force on the One hundred and eighty first day from the date of its publication in the Official Gazette (June 15, 2021). This translates to December 13, 2021. **6. Target Audience and Stakeholders:** The primary target audience and stakeholders are: * **Manufacturers and producers of Ortho Phosphoric Acid:** They are directly impacted by the mandatory quality control and certification requirements. * **Importers and distributors of Ortho Phosphoric Acid:** These stakeholders are affected to the extent that they deal with domestic sales, as exports are excluded. * **Consumers and end-users of Ortho Phosphoric Acid:** They benefit from the assurance of quality and adherence to standards. * **Bureau of Indian Standards (BIS):** As the certifying and enforcing authority, BIS has a key role in implementing and overseeing the policy. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Bureau of Indian Standards (BIS) is the key responsible body. * **Timelines:** The policy comes into effect 181 days after its publication date (June 15, 2021), which is December 13, 2021. This provides manufacturers with a transition period to comply with the new regulations. * **Procedures (Inferred):** Manufacturers will need to apply for a license from BIS to use the Standard Mark. They will also need to ensure their products meet the specifications outlined in IS 798: 2020. BIS will likely conduct inspections and audits to ensure compliance. **8. Expected Outcomes / Impact of Changes:** The likely intended outcomes and impacts of the policy are: * **Improved Quality of Ortho Phosphoric Acid:** By mandating adherence to Indian Standards, the policy aims to ensure a consistent and acceptable level of quality for the product. * **Consumer Protection:** Ensuring quality standards will protect consumers from substandard or harmful products. * **Fair Trade Practices:** The policy promotes fair competition by establishing a level playing field for all manufacturers and suppliers. * **Increased Compliance Costs:** Manufacturers will likely incur costs associated with obtaining BIS certification and ensuring their production processes meet the required standards. * **Enhanced Market Confidence:** The presence of the Standard Mark will likely increase consumer confidence in the quality of domestically produced Ortho Phosphoric Acid. **9. Conclusion:** The Ortho Phosphoric Acid Quality Control Order, 2021, is a significant policy measure aimed at regulating the quality of Ortho Phosphoric Acid in the Indian market. By mandating compliance with Indian Standards and certification through the BIS, the policy is expected to improve product quality, protect consumers, and promote fair trade practices. Manufacturers need to understand the requirements and timelines for compliance to avoid penalties. This policy demonstrates the government's commitment to quality control and consumer protection in the chemical industry.

Key Entities Referenced